224 related articles for article (PubMed ID: 19655389)
1. Metallothionein-I+II in neuroprotection.
Pedersen MØ; Jensen R; Pedersen DS; Skjolding AD; Hempel C; Maretty L; Penkowa M
Biofactors; 2009; 35(4):315-25. PubMed ID: 19655389
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein I and II mitigate age-dependent secondary brain injury.
Natale JE; Knight JB; Cheng Y; Rome JE; Gallo V
J Neurosci Res; 2004 Nov; 78(3):303-14. PubMed ID: 15389833
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family.
Ambjørn M; Asmussen JW; Lindstam M; Gotfryd K; Jacobsen C; Kiselyov VV; Moestrup SK; Penkowa M; Bock E; Berezin V
J Neurochem; 2008 Jan; 104(1):21-37. PubMed ID: 17986228
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression.
Penkowa M; Camats J; Giralt M; Molinero A; Hernández J; Carrasco J; Campbell IL; Hidalgo J
Glia; 2003 May; 42(3):287-306. PubMed ID: 12673834
[TBL] [Abstract][Full Text] [Related]
6. New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration.
Chung RS; Hidalgo J; West AK
J Neurochem; 2008 Jan; 104(1):14-20. PubMed ID: 17986229
[TBL] [Abstract][Full Text] [Related]
7. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
Espejo C; Martínez-Cáceres EM
Ann N Y Acad Sci; 2005 Jun; 1051():88-96. PubMed ID: 16126947
[TBL] [Abstract][Full Text] [Related]
8. Metallothioneins are multipurpose neuroprotectants during brain pathology.
Penkowa M
FEBS J; 2006 May; 273(9):1857-70. PubMed ID: 16640552
[TBL] [Abstract][Full Text] [Related]
9. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice.
Penkowa M; Carrasco J; Giralt M; Molinero A; Hernández J; Campbell IL; Hidalgo J
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1174-89. PubMed ID: 10950378
[TBL] [Abstract][Full Text] [Related]
10. Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury.
Penkowa M; Tio L; Giralt M; Quintana A; Molinero A; Atrian S; Vasák M; Hidalgo J
J Neurosci Res; 2006 May; 83(6):974-84. PubMed ID: 16493670
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein isoforms (I+II and III) and interleukin-6 in the hippocampus of old rats: may their concomitant increments lead to neurodegeneration?
Mocchegiani E; Giacconi R; Fattoretti P; Casoli T; Cipriano C; Muti E; Malavolta M; DiStefano G; Bertoni-Freddari C
Brain Res Bull; 2004 Mar; 63(2):133-42. PubMed ID: 15130702
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein-1+2 protect the CNS after a focal brain injury.
Giralt M; Penkowa M; Lago N; Molinero A; Hidalgo J
Exp Neurol; 2002 Jan; 173(1):114-28. PubMed ID: 11771944
[TBL] [Abstract][Full Text] [Related]
13. Expression and Purification of glutathione transferase-small ubiquitin-related modifier-metallothionein fusion protein and its neuronal and hepatic protection against D-galactose-induced oxidative damage in mouse model.
Huang Y; Su Z; Li Y; Zhang Q; Cui L; Su Y; Ding C; Zhang M; Feng C; Tan Y; Feng W; Li X; Cai L
J Pharmacol Exp Ther; 2009 May; 329(2):469-78. PubMed ID: 19208897
[TBL] [Abstract][Full Text] [Related]
14. [Metallothionein-I/II in brain injury repair mechanism and its application in forensic medicine].
Li D; Li RB; Lin JL
Fa Yi Xue Za Zhi; 2013 Oct; 29(5):365-7, 377. PubMed ID: 24466778
[TBL] [Abstract][Full Text] [Related]
15. Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice.
Wiese L; Kurtzhals JA; Penkowa M
Exp Neurol; 2006 Jul; 200(1):216-26. PubMed ID: 16624296
[TBL] [Abstract][Full Text] [Related]
16. Cell death in the injured brain: roles of metallothioneins.
Pedersen MØ; Larsen A; Stoltenberg M; Penkowa M
Prog Histochem Cytochem; 2009; 44(1):1-27. PubMed ID: 19348909
[TBL] [Abstract][Full Text] [Related]
17. Metallothioneins I and II: neuroprotective significance during CNS pathology.
Stankovic RK; Chung RS; Penkowa M
Int J Biochem Cell Biol; 2007; 39(3):484-9. PubMed ID: 17097331
[TBL] [Abstract][Full Text] [Related]
18. Peptides modeled after the alpha-domain of metallothionein induce neurite outgrowth and promote survival of cerebellar granule neurons.
Asmussen JW; Ambjørn M; Bock E; Berezin V
Eur J Cell Biol; 2009 Aug; 88(8):433-43. PubMed ID: 19446362
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein.
Liu Q; Wang G; Zhou G; Tan Y; Wang X; Wei W; Liu L; Xue W; Feng W; Cai L
Toxicol Lett; 2009 Dec; 191(2-3):314-20. PubMed ID: 19808082
[TBL] [Abstract][Full Text] [Related]
20. Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects.
Formigari A; Irato P; Santon A
Comp Biochem Physiol C Toxicol Pharmacol; 2007 Nov; 146(4):443-59. PubMed ID: 17716951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
